Issued Patents 2022
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11491167 | Combination product of Bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Guangfeng Wang | 2022-11-08 |
| 11491168 | Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof | Yifan Zhai | 2022-11-08 |
| 11478470 | Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibitor and BTK inhibitor and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Douglas Dong FANG, Guangfeng Wang, Guoqin Zhai | 2022-10-25 |
| 11478469 | Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseases | Yifan Zhai, Qiuqiong Tang, Douglas Dong FANG | 2022-10-25 |
| 11478477 | Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor and EGFR inhibitor | Yifan Zhai, Douglas Dong FANG, Guangfeng Wang | 2022-10-25 |
| 11452716 | Pharmaceutical composition and use thereof | Yifan Zhai, Douglas Dong FANG, Qiuqiong Tang | 2022-09-27 |
| 11395815 | Compound for treating osteoarthritis | Yifan Zhai, Douglas Dong FANG, Saijie ZHU | 2022-07-26 |
| 11298339 | Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disorders | Yifan Zhai, Xiaoyong Zhang, Jinlin Hou | 2022-04-12 |